[go: up one dir, main page]

ZA200303826B - Immunoprotective recombinent antigen from Anaplasma marginale, vaccine compositions and methods of use. - Google Patents

Immunoprotective recombinent antigen from Anaplasma marginale, vaccine compositions and methods of use.

Info

Publication number
ZA200303826B
ZA200303826B ZA200303826A ZA200303826A ZA200303826B ZA 200303826 B ZA200303826 B ZA 200303826B ZA 200303826 A ZA200303826 A ZA 200303826A ZA 200303826 A ZA200303826 A ZA 200303826A ZA 200303826 B ZA200303826 B ZA 200303826B
Authority
ZA
South Africa
Prior art keywords
recombinent
immunoprotective
antigen
methods
vaccine compositions
Prior art date
Application number
ZA200303826A
Other languages
English (en)
Inventor
Jose De Jesus De La Fuente
Katherine M Kocan
Jose Carlos Garcia-Garcia
Edmour F Blouin
Original Assignee
Univ Oklahoma State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Oklahoma State filed Critical Univ Oklahoma State
Publication of ZA200303826B publication Critical patent/ZA200303826B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0233—Rickettsiales, e.g. Anaplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ZA200303826A 2000-10-30 2003-05-16 Immunoprotective recombinent antigen from Anaplasma marginale, vaccine compositions and methods of use. ZA200303826B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24433300P 2000-10-30 2000-10-30

Publications (1)

Publication Number Publication Date
ZA200303826B true ZA200303826B (en) 2005-05-27

Family

ID=22922300

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200303826A ZA200303826B (en) 2000-10-30 2003-05-16 Immunoprotective recombinent antigen from Anaplasma marginale, vaccine compositions and methods of use.

Country Status (7)

Country Link
US (1) US6939549B2 (xx)
EP (1) EP1363661A2 (xx)
AU (2) AU2002230879B2 (xx)
BR (1) BR0115095A (xx)
MX (1) MXPA03003876A (xx)
WO (1) WO2002036159A2 (xx)
ZA (1) ZA200303826B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6979451B1 (en) * 2000-10-30 2005-12-27 The Board Of Regents For Oklahoma State University Recombinant antigen MSP1a from anaplasma marginale to reduce infections in ticks, vaccine compositions and methods of use
US6939549B2 (en) * 2000-10-30 2005-09-06 The Board Of Regents For Oklahoma State University Immunoprotective recombinant antigen from anaplasma marginale, vaccine compositions and methods of use
US20050260229A1 (en) * 2000-10-30 2005-11-24 De La Fuente Jose De Jesus Glycans of Anaplasma marginale major surface protein 1a, pharmaceutical compositions and methods of use
EP2307559B1 (en) * 2008-03-03 2015-09-02 Imigene, Inc. Infection mediated foam dissolution rate measurement
US9580758B2 (en) 2013-11-12 2017-02-28 Luc Montagnier System and method for the detection and treatment of infection by a microbial agent associated with HIV infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674860A (en) * 1969-07-14 1972-07-04 Diamond Lab Inc Anaplasmosis vaccines
US5549898A (en) 1985-03-25 1996-08-27 Mcguire; Travis C. Immunogenic anaplasma marginale surface antigens, compositions, and methods of use
GR860772B (en) * 1985-03-25 1986-07-21 Univ Washington Anaplasma marginale subunit antigen for vaccination and diagnosis
US4956278A (en) 1988-02-23 1990-09-11 Louisiana State University Anaplasma marginale antigen, antigen compositions, vaccine and process for the production of said antigen, antigen compositions and vaccine
US5798219A (en) 1993-11-23 1998-08-25 The United States Of America As Represented By The Secretary Of Agriculture Serological identification of cattle, sheep or goats infected with anaplasma species
US5869335A (en) 1995-08-25 1999-02-09 Regents Of The University Of Minnesota Method of growing rickettsiae in Ixodes scapularis tick cell culture and preparing antigens and vaccines of rickettsiae
US6025338A (en) 1996-10-17 2000-02-15 University Of Florida Nucleic acid vaccines against rickettsial diseases and methods of use
US6939549B2 (en) * 2000-10-30 2005-09-06 The Board Of Regents For Oklahoma State University Immunoprotective recombinant antigen from anaplasma marginale, vaccine compositions and methods of use
EP1534328A4 (en) * 2002-04-29 2007-01-10 Univ Oklahoma State PROTECTIVE ANTIQUE TO COMBAT REVERSATION WITH IXODES SPECIES

Also Published As

Publication number Publication date
WO2002036159A3 (en) 2003-07-10
US6939549B2 (en) 2005-09-06
WO2002036159A2 (en) 2002-05-10
BR0115095A (pt) 2005-12-13
MXPA03003876A (es) 2004-12-02
AU3087902A (en) 2002-05-15
AU2002230879B2 (en) 2006-11-16
EP1363661A2 (en) 2003-11-26
US20020127242A1 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
EG24742A (en) Vaccine composition.
CY2019029I2 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
HUP0302128A3 (en) Anti-dual integrin antibodies, compositions, methods and uses
MXPA03002453A (es) Uso de imidazoquinolinaminas como mejoradores de vacunacion de acido desoxirribonucleico.
IL161968A0 (en) Anti-il-6 antibodies, compositions, methods and uses
NL300390I1 (en) Anti-IL-12 antibodies, compositions, methods and uses.
MXPA03008961A (es) Composicion de vacuna.
MXPA02012652A (es) Dispositivo para probar saliva y reportar.
IL151942A0 (en) Compositions and methods for enhancing immunogenicity of antigens
ZA200109189B (en) Artificial stone and formation thereof.
ZA200207589B (en) Multivalent antibodies and uses therefor. Multivalent antibodies and uses thereof.
HUP0302117A3 (en) Vaccine composition
DE60224748D1 (de) Kornorientierte Keramik und Verfahren zu ihrer Herstellung, sowie anisotrop geformtes Pulver und Verfahren zu seiner Herstellung
ZA200300545B (en) Novel heteroaryl derivatives and use thereof as anti-tumour agents.
ZA200207002B (en) Salmonella vaccine materials and methods.
MXPA03005410A (es) Metodos para hacer materiales que tienen memoria de forma.
MXPA03007915A (es) Vacuna.
MXPA01009900A (es) Formulaciones de taxano que tienen solubilidad mejorada.
ZA200302014B (en) Methods and compositions for promoting the maturation of monocytes.
AU2002359495A8 (en) Anti-tnf antibodies, compositions, methods and uses
IL161235A0 (en) Fsh composition, its preparation and use
ZA200303826B (en) Immunoprotective recombinent antigen from Anaplasma marginale, vaccine compositions and methods of use.
AP2006003530A0 (en) Immunogenic HIV compositions and related methods.
MXPA03002875A (es) Composicion de vacuna y metodo de estabilizacion.
AU2002365269A8 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses